Paul J. Clancy
2015
In 2015, Paul J. Clancy earned a total compensation of $4M as EVP, Chief Financial Officer at Biogen, a 16% decrease compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $45,960 |
|---|---|
| Non-Equity Incentive Plan | $284,655 |
| Salary | $747,498 |
| Stock Awards | $2,543,374 |
| Other | $332,115 |
| Total | $3,953,602 |
Clancy received $2.5M in stock awards, accounting for 64% of the total pay in 2015.
Clancy also received $46K of change in pension value and nonqualified deferred compensation earnings, $284.7K in non-equity incentive plan, $747.5K in salary and $332.1K in other compensation.
Rankings
In 2015, Paul J. Clancy's compensation ranked 2,215th out of 13,638 executives tracked by ExecPay. In other words, Clancy earned more than 83.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,215 out of 13,638 | 84th |
Division Manufacturing | 793 out of 5,190 | 85th |
Major group Chemicals And Allied Products | 283 out of 1,854 | 85th |
Industry group Drugs | 222 out of 1,528 | 86th |
Industry Biological Products, Except Diagnostic Substances | 38 out of 254 | 85th |
Source: SEC filing on April 15, 2016.
Clancy's colleagues
We found six more compensation records of executives who worked with Paul J. Clancy at Biogen in 2015.
2015
George Scangos
Biogen
Chief Executive Officer
2015
John Cox
Biogen
EVP, Pharmaceutical Operations and Technology
2015
Douglas Williams
Biogen
Former EVP, Research and Development
2015
Stuart Kingsley
Biogen
Former EVP, Global Operations
2015
Susan Alexander
Biogen
Chief Legal Officer
2015
Kenneth DiPietro
Biogen